Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications using diffusion innovation theory understand challenges opportunities advancing use
2023 Italian Society of Hygiene, Preventive Medicine, and Public Health (SITI) Conference Share on: Thursday, October 12 - Saturday, October 14, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at the 2023 …
… disease models to inform your analyses and help you better understand the potential impact of your novel healthcare … intervention. You rely on realistic disease models to understand and communicate the value of your healthcare … affects disease transmission, health outcomes, resource use, and costs. …
… March 12, 2025, 3pm - Friday, March 14, 2025, 1pm Learn to Use Target Trial Emulation for Regulatory Real-World Evidence … This in-person course will give you the resources to understand and implement the target trial emulation framework … analysis, and interpretation of causal regulatory studies using the target trial emulation framework. Learning …
… often respond to these unsolicited requests from payers using evidence requirements outlined in the Academy of … for possible FDA approval of the product or of the new use Product pricing information Patient utilization …
Gene Therapy Keep your gene therapy development on track The paradigm of regenerative medicine development is changing. Expedited regulatory approvals can help developers, but only if they are timely with strategic planning and fully versed in the latest …
… definitions or diagnostic or treatment guidelines? You can use a Delphi panel in these situations to provide actionable … along with a set of recommendations on how you can use the results to inform your product development decisions. …
… Product Profile (TPP) Assessment A Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis Proven and Projected …
… a European-wide level. The 4 clinical domains are: current use (background information on patient population, burden of disease, comparators and their use); technical (description of the technology and its … meet these aims remains to be seen. It is important to understand that the JCA process runs in parallel to the …
Discrete Choice Experiments and Conjoint Analysis As a pharmaceutical or device manufacturer, your products have different attributes related to safety, efficacy, mode of administration, etc. and so do your competitor’s products—but, do you know which of …
Webinar: Strategic Planning for Orphan Drugs Share on: Tuesday, June 7, 2022, 10 - 11am Maximizing Asset Value Through Evidence Generation Planning When developing new products to treat rare diseases, it is particularly challenging to demonstrate …